HomeCompareCVTGF vs MRK

CVTGF vs MRK: Dividend Comparison 2026

CVTGF yields 1.32% · MRK yields 2.76%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 CVTGF wins by $65.9K in total portfolio value· pulled ahead in Year 7
10 years
CVTGF
CVTGF
● Live price
1.32%
Share price
$49.00
Annual div
$0.65
5Y div CAGR
60%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$122.7K
Annual income
$52,188.01
Full CVTGF calculator →
MRK
Merck & Co. Inc.
● Live price
2.76%
Share price
$120.31
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$56.8K
Annual income
$9,798.13
Full MRK calculator →

Portfolio growth — CVTGF vs MRK

📍 CVTGF pulled ahead of the other in Year 7

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodCVTGFMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, CVTGF + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
CVTGF pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

CVTGF
Annual income on $10K today (after 15% tax)
$112.55/yr
After 10yr DRIP, annual income (after tax)
$44,359.81/yr
MRK
Annual income on $10K today (after 15% tax)
$234.56/yr
After 10yr DRIP, annual income (after tax)
$8,328.41/yr
At 15% tax rate, CVTGF beats the other by $36,031.40/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of CVTGF + MRK for your $10,000?

CVTGF: 50%MRK: 50%
100% MRK50/50100% CVTGF
Portfolio after 10yr
$89.7K
Annual income
$30,993.08/yr
Blended yield
34.54%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

CVTGF
No analyst data
Altman Z
5.5
Piotroski
5/9
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+6.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

CVTGF buys
0
MRK buys
0
No recent congressional trades found for CVTGF or MRK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricCVTGFMRK
Forward yield1.32%2.76%
Annual dividend / share$0.65$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR60%32.7%
Portfolio after 10y$122.7K$56.8K
Annual income after 10y$52,188.01$9,798.13
Total dividends collected$96.1K$28.9K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: CVTGF vs MRK ($10,000, DRIP)

YearCVTGF PortfolioCVTGF Income/yrMRK PortfolioMRK Income/yrGap
1$10,912$211.86$11,206$366.19$294.00MRK
2$12,021$345.69$12,650$502.35$629.00MRK
3$13,432$569.48$14,407$694.19$975.00MRK
4$15,324$951.52$16,585$967.82$1.3KMRK
5$18,020$1,623.21$19,342$1,363.89$1.3KMRK
6$22,136$2,854.25$22,913$1,947.19$777.00MRK
7← crossover$28,928$5,242.83$27,662$2,823.89+$1.3KCVTGF
8$41,198$10,245.36$34,159$4,173.35+$7.0KCVTGF
9$65,901$21,818.47$43,337$6,308.80+$22.6KCVTGF
10$122,702$52,188.01$56,776$9,798.13+$65.9KCVTGF

CVTGF vs MRK: Complete Analysis 2026

CVTGFStock

Clairvest Group Inc. is a private equity firm specializing in mid-market, growth equity investments, growth capital, buyouts, and consolidating industries and add-on acquisitions. It seeks to invest in small and mid-sized gaming and casino, local market gaming, healthcare, equipment rental, facility services, oilfield services, waste management, business services, consumer services, aerospace, automotive aftermarket, collision repair, food, beverage and co-packing, defense, document management, warranty, contact manufacturing, environmental services, rental services, residential HVAC services, healthcare services, multiunit healthcare, insurance services, IT services, logistics and transportation, mining services, packaging, pest control, specialty aviation, education, software (mature), textile rental, utility services, water, building products, government services, industrial distribution and services, information technology and information services, media and marketing, non-destructive testing, renewable energy, property management, and restaurants. The firm typically invests in companies based in North America including United States and Canada. It seeks to make equity investments between CAD$25 million ($19.53 million) and CAD$100 million ($78.14 million) in its portfolio company with EBITDA between CAD$5 million ($3.81 million) and CAD$50 million ($39.07 million). The firm does not require majority stake and takes controlling or minority investments. It invests its own capital and seeks to take a board seat on its portfolio companies. The firm also makes co-investments. The firm typically exits its investments through market share offering, a strategic sale or sale to a financial buyer. Clairvest Group Inc. was founded in 1987 and is based in Toronto, Canada.

Full CVTGF Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this CVTGF vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

CVTGF vs SCHDCVTGF vs JEPICVTGF vs OCVTGF vs KOCVTGF vs MAINCVTGF vs JNJCVTGF vs ABBVCVTGF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.